Progyny, Inc. OCI, before Reclassifications, Net of Tax, Attributable to Parent
Progyny, Inc. (PGNY) reported OCI, before Reclassifications, Net of Tax, Attributable to Parent of -$32.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent · last filed 2026-08-07
- Progyny, Inc. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2026-06-30 was -$32.00K, a 129.63% decline year-over-year.
- Progyny, Inc. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2026-03-31 was -$182.00K, a 356.34% decline year-over-year.
- Progyny, Inc. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-12-31 was $79.00K.
- Progyny, Inc. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-09-30 was $201.00K, a 59.64% decline year-over-year.
- Progyny, Inc. oci, before reclassifications, net of tax, attributable to parent for fiscal 2025 was $459.00K, a 89.87% decline from fiscal 2024.
- Progyny, Inc. oci, before reclassifications, net of tax, attributable to parent for fiscal 2024 was $4.53M, a 26.06% decline from fiscal 2023.
- Progyny, Inc. oci, before reclassifications, net of tax, attributable to parent for fiscal 2023 was $6.13M.
| Period end | OCI, before Reclassifications, Net of Tax, Attributable to Parent 3 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 6 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 9 month | OCI, before Reclassifications, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$32.00K 10-Q · filed 2026-08-07 | -$214.00K 10-Q · filed 2026-08-07 | -$135.00K derived: sum of 3 quarters · filed 2026-08-07 | $66.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$182.00K 10-Q · filed 2026-05-08 | -$103.00K derived: sum of 2 quarters · filed 2026-05-08 | $98.00K derived: sum of 3 quarters · filed 2026-05-08 | $206.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $280.00K derived: sum of 2 quarters · filed 2026-02-27 | $388.00K derived: sum of 3 quarters · filed 2026-08-07 | $459.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $201.00K 10-Q · filed 2025-11-07 | $309.00K derived: sum of 2 quarters · filed 2026-08-07 | $380.00K 10-Q · filed 2025-11-07 | $89.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $108.00K 10-Q · filed 2026-08-07 | $179.00K 10-Q · filed 2026-08-07 | -$112.00K derived: sum of 3 quarters · filed 2026-08-07 | $386.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $71.00K 10-Q · filed 2026-05-08 | -$220.00K derived: sum of 2 quarters · filed 2026-05-08 | $278.00K derived: sum of 3 quarters · filed 2026-05-08 | $2.18M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $207.00K derived: sum of 2 quarters · filed 2026-02-27 | $2.11M derived: sum of 3 quarters · filed 2026-02-27 | $4.53M 10-K · filed 2026-02-27 |
| 2024-09-30 | $498.00K 10-Q · filed 2025-11-07 | $2.40M derived: sum of 2 quarters · filed 2025-11-07 | $4.82M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $1.91M 10-Q · filed 2025-08-08 | $4.32M 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | $2.42M 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $6.13M 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |